Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Treatment for Acute hepatitis C

Effectiveness
96%
Safety Score
65%
Clinical Trials
1
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
0
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Outcomes

for Acute hepatitis C

Efficacy Outcomes
Overall Effectiveness
+96%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir in Acute hepatitis C

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

NCT02634008COMPLETEDPHASE3
View Study
83 participants
INTERVENTIONAL
Sydney, Australia +10 more
Started: Jun 1, 2016